EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study

Ivan Nicolas Ayala, Cristian Soto Jacome, David Toro-Tobon iD, Elizabeth Golembiewski, Andrea Garcia-Bautista, Jessica Hidalgo, Sandra Cordova-Madera, Raghda Al Anbari, Jessica Sohn R, Naykky Singh Ospina iD, Spyridoula Maraka, Marina Joseph und 1 weitere

The Journal of Clinical Endocrinology & Metabolism · 18.01.2024 · 109 (2) · e765-e772

DOI: 10.1210/clinem/dgad517 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 01.09.2023. Verfasst von Ivan Nicolas Ayala und 12 weiteren Autor:innen. Beteiligte Einrichtung: Knowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA. Hauptthemen laut MEDLINE: Thyroxine, Hypothyroidism. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HSRD VA, NCI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Levothyroxine is one of the most prescribed medications in the United States.

Objective

This study explores the appropriateness of levothyroxine prescriptions.

Methods

A retrospective multicenter study was conducted on adult patients who were prescribed levothyroxine for the first time between 2017 and 2020 at three academic centers in the United States. We classified each case of levothyroxine initiation into one of three mutually exclusive categories: appropriate (clinically supported), indeterminate (clinically unclear), or nonevidence based (NEB, not clinically supported).

Results

A total of 977 participants were included. The mean age was 55 years (SD 19), there was female (69%) and White race predominance (84%), and 44% had possible hypothyroid symptoms. Nearly half of the levothyroxine prescriptions were considered NEB (528, 54%), followed by appropriate (307, 31%) and indeterminate (118, 12%). The most common reason for NEB prescription was an index thyrotropin (TSH) value of less than 10 mIU/L without previous TSH or thyroxine values (131/528, 25%), for appropriate prescription, was overt hypothyroidism (163/307, 53%), and for an indeterminate prescription was a nonconfirmed subclinical hypothyroidism with TSH greater than or equal to 10 mIU/L (no confirmatory testing) (51/118, 43%). In multivariable analysis, being female (odds ratio [OR]: 1.3; 95% CI, 1.0-1.7) and prescription by a primary care provider (OR: 1.5; 95% CI, 1.2-2.0) were associated with NEB prescriptions.

Conclusion

There is a considerable proportion of NEB levothyroxine prescriptions. These results call for additional research to replicate these findings and to explore the perspective of those prescribing and receiving levothyroxine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroxineHypothyroidismAdultHumansFemaleMiddle AgedMaleRetrospective StudiesThyrotropinOdds Ratio

Substanzen

ThyroxineThyrotropin

Autor:innen und Institutionen

  • Knowledge and Evaluation Research Unit, Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA.
  • Division of Endocrinology, Diabetes, Metabolism and Nutrition, Department of Medicine, Mayo Clinic, Rochester, MN 55902, USA.
  • Department of Medicine, MetroWest Medical Center, Framingham, MA 01702, USA.
  • Division of Endocrinology, Department of Medicine, University of Florida, Gainesville, FL 32610, USA.
  • Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Section of Endocrinology, Medicine Service, Central Arkansas Veterans Healthcare System, Little Rock, AR 72205, USA.

ORCID-Profile: David Toro-Tobon, Naykky Singh Ospina, Juan P Brito

Förderung

  • HSRD VA
  • NCI NIH HHS
  • NCATS NIH HHS
  • Arkansas Biosciences Institute
  • Office of Health Services Research and Development Service of the US Department of Veterans Affairs
  • National Center for Advancing Translational Sciences of the National Institutes of Health
  • National Cancer Institute of the National Institutes of Health

Zitieren

APA

Ayala, I. N., Soto Jacome, C., Toro-Tobon, D., Golembiewski, E., Garcia-Bautista, A., Hidalgo, J., Cordova-Madera, S., Al Anbari, R., Sohn R, J., Singh Ospina, N., Maraka, S., Joseph, M., & Brito, J. P. (2024). Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study. The Journal of Clinical Endocrinology & Metabolism, 109(2), e765-e772. https://doi.org/10.1210/clinem/dgad517

Vancouver

Ayala IN, Soto Jacome C, Toro-Tobon D, Golembiewski E, Garcia-Bautista A, Hidalgo J, et al. Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study. The Journal of Clinical Endocrinology & Metabolism. 2024;109(2):e765-e772. doi:10.1210/clinem/dgad517

BibTeX
@article{Ayala2024,
  author = {Ayala, Ivan Nicolas and Soto Jacome, Cristian and Toro-Tobon, David and Golembiewski, Elizabeth and Garcia-Bautista, Andrea and Hidalgo, Jessica and Cordova-Madera, Sandra and Al Anbari, Raghda and Sohn R, Jessica and Singh Ospina, Naykky and Maraka, Spyridoula and Joseph, Marina and Brito, Juan P},
  title = {Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  volume = {109},
  number = {2},
  pages = {e765--e772},
  doi = {10.1210/clinem/dgad517}
}
Kostenlos starten →